Early administration of tofacitinib in COVID‐19 pneumonitis: An open randomised controlled trial
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.13898
Abstract: Controversies on sub‐populations most sensitive to therapy and the best timing of starting the treatment still surround the use of immunomodulatory drugs in COVID‐19. read more here.
Keywords: open randomised; early administration; covid pneumonitis; pneumonitis open ... See more keywords
Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID‐19 pneumonitis
Sign Up to like & getrecommendations! Published in 2023 at "Physiological Reports"
DOI: 10.14814/phy2.15660
Abstract: Reduced carbon monoxide diffusing capacity (DLCO) is common after recovery from severe COVID‐19 pneumonitis. The extent to which this relates to alveolar membrane dysfunction as opposed to vascular injury is uncertain. Simultaneous measurement of nitric… read more here.
Keywords: severe covid; gas; nitric oxide; covid pneumonitis ... See more keywords